These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30565246)

  • 21. The role of regulatory T Cells in autoimmune orchitis.
    Jacobo P
    Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome.
    Larmonier CB; Shehab KW; Ghishan FK; Kiela PR
    Biomed Res Int; 2015; 2015():504638. PubMed ID: 26583115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.
    Li J; Butcher J; Mack D; Stintzi A
    Inflamm Bowel Dis; 2015 Jan; 21(1):139-53. PubMed ID: 25248007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T-cell differentiation and their function in immune regulation.
    Piccioni M; Chen Z; Tsun A; Li B
    Adv Exp Med Biol; 2014; 841():67-97. PubMed ID: 25261205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy with iTreg and nTreg Cells in a Murine Model of Inflammatory Bowel Disease.
    Haribhai D; Chatila TA; Williams CB
    Methods Mol Biol; 2016; 1422():197-211. PubMed ID: 27246035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease.
    Bolton C; Smillie CS; Pandey S; Elmentaite R; Wei G; Argmann C; Aschenbrenner D; James KR; McGovern DPB; Macchi M; Cho J; Shouval DS; Kammermeier J; Koletzko S; Bagalopal K; Capitani M; Cavounidis A; Pires E; Weidinger C; McCullagh J; Arkwright PD; Haller W; Siegmund B; Peters L; Jostins L; Travis SPL; Anderson CA; Snapper S; Klein C; Schadt E; Zilbauer M; Xavier R; Teichmann S; Muise AM; Regev A; Uhlig HH
    Gastroenterology; 2022 Mar; 162(3):859-876. PubMed ID: 34780721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
    Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
    J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease.
    Hirata Y; Ihara S; Koike K
    Pharmacol Res; 2016 Nov; 113(Pt A):574-584. PubMed ID: 27702681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
    Visperas A; Vignali DA
    J Immunol; 2016 Nov; 197(10):3762-3770. PubMed ID: 27815439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy.
    Li Z; Vermeire S; Bullens D; Ferrante M; Van Steen K; Noman M; Rutgeerts P; Ceuppens JL; Van Assche G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2418-28. PubMed ID: 26308438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype.
    Lord JD; Long SA; Shows DM; Thorpe J; Schwedhelm K; Chen J; Kita M; Buckner JH
    Clin Immunol; 2018 Aug; 193():24-32. PubMed ID: 29842945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Epistatic Interaction between Themis1 and Vav1 Modulates Regulatory T Cell Function and Inflammatory Bowel Disease Development.
    Pedros C; Gaud G; Bernard I; Kassem S; Chabod M; Lagrange D; Andréoletti O; Dejean AS; Lesourne R; Fournié GJ; Saoudi A
    J Immunol; 2015 Aug; 195(4):1608-16. PubMed ID: 26163585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?
    Fantini MC; Monteleone G
    Inflamm Bowel Dis; 2017 Oct; 23(10):1682-1688. PubMed ID: 28906289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of Oral Tolerance.
    Tordesillas L; Berin MC
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):107-117. PubMed ID: 29488131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation.
    Togashi Y; Nishikawa H
    Curr Top Microbiol Immunol; 2017; 410():3-27. PubMed ID: 28879523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.
    Abron JD; Singh NP; Mishra MK; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G220-G230. PubMed ID: 29672155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T Cells in Systemic Sclerosis.
    Frantz C; Auffray C; Avouac J; Allanore Y
    Front Immunol; 2018; 9():2356. PubMed ID: 30374354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
    Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation.
    Mehta M; Ahmed S; Dryden G
    Innate Immun; 2017 Aug; 23(6):497-505. PubMed ID: 28770665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease.
    Uhlig HH; Schwerd T
    Inflamm Bowel Dis; 2016 Jan; 22(1):202-12. PubMed ID: 26512716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.